VINCENT MILES
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
DROR BRANDWEIN,
ROBERT CITRON,
TODD T. FOLEY,
ANSBERT K. GADICKE,
BARD J. GEESAMAN,
RONI MAMLUK,
DALIA MEGIDDO,
SCOTT MINICK,
CHAIME ORLEV,
FREDRIC D. PRICE,
JOHN A. SCARLETT,
BENJAMIN T. SPORN,
DAVID M. STACK,
SAM TEICHMAN
DIRECTOR
TOM BURKE,
ROBERT CARPENTER,
BERT CHENARD, PH.D.,
JEAN GEORGE,
PAUL GOLDENHEIM,
STEVEN HALL,
STEVEN E. HALL,
RUSSELL HERNDON,
MAGDALENE MORAN, PH.D.
PROMOTER
JAMES ABELL,
N/A ABINGWORTH BIOVENTURES VII GP LP,
N/A ABINGWORTH LLP,
N/A ABINGWORTH MANAGEMENT INC,
MICHAEL BIGHAM,
STEPHEN BUNTING,
SHELLEY CHU,
KENNETH HAAS,
TIMOTHY HAINES,
JOHN HEARD,
DAVID LEATHERS,
GENGHIS LLOYD-HARRIS,
KURT VON EMSTER
DIRECTOR
TOM BURKE,
ROBERT CARPENTER,
BERT CHENARD, PH.D.,
JEAN GEORGE,
PAUL GOLDENHEIM,
STEVEN HALL,
STEVEN E. HALL,
RUSSELL HERNDON,
MAGDALENE MORAN, PH.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2019-05-31
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2018-07-18
D/A
VENTURE CAPITAL FUND
DECLINE TO DISCLOSE
Equity
2016-11-07
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2017-06-29
D/A
VENTURE CAPITAL FUND
DECLINE TO DISCLOSE
Equity
2016-11-07
D
VENTURE CAPITAL FUND
DECLINE TO DISCLOSE
Equity
2016-11-07
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-03-17
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2014-12-16
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2014-12-16
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2012-07-11
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2009-09-04
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2009-08-21